For example, miR-524-5p inhibits angiogenesis in CRC by targeting WNK1, reducing tumor cell proliferation, inducing cell cycle arrest, and decreasing the production of vascular endothelial growth factor, thereby exhibiting inhibitory effects on tumor growth in both in vitro and in vivo experiments [38]. Here, WNK1 is linked to neoplasm.